Advertisement

Reactions Weekly

, Volume 1769, Issue 1, pp 183–183 | Cite as

Durvalumab/nivolumab/tremelimumab

Various toxicities: 3 case reports
Case report
  • 16 Downloads

Reference

  1. Reinmuth N, et al. Management of adverse events in immune oncology - Practical aspects of immune-related adverse events during immune oncological treatment. Deutsche Medizinische Wochenschrift 144: 346-353, No. 5, Mar 2019. Available from: URL: http://doi.org/10.1055/a-0739-8194 [German; summarised from a translation] - GermanyCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations